Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea flag South Korea · Delayed Price · Currency is KRW
29,250
+50 (0.17%)
At close: Aug 14, 2025, 3:30 PM KST
0.17%
Market Cap1.48T
Revenue (ttm)141.00B
Net Income (ttm)-1.69B
Shares Out50.74M
EPS (ttm)-33.58
PE Ration/a
Forward PE132.98
Dividendn/a
Ex-Dividend Daten/a
Volume367,778
Average Volume328,991
Open29,600
Previous Close29,200
Day's Range29,100 - 30,000
52-Week Range24,000 - 52,000
Beta0.82
RSI60.66
Earnings DateAug 14, 2025

About Hanall Biopharma

Hanall Biopharma Co., Ltd., a pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally. The company offers prescription drugs and over-the-counter products for the treatment of diarrhea, prostatic hyperplasia, androgenetic alopecia, chronic renal failure, hypoparathyroidism, vitamin D-resistant rickets, osteomalacia, osteoporosis, prostate cancer, toxic liver disease, chronic hepatitis, liver cirrhosis, male pattern baldness, functional dyspepsia, diabetes, bacterial infections, peripheral vascul... [Read more]

Sector Healthcare
Founded 1973
Employees 304
Stock Exchange Korea Stock Exchange
Ticker Symbol 009420
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.